Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > Tic Toc goes the clock, DEA
View:
Comment by subaru1 on Feb 02, 2024 10:57am
same old story since a year, blalabla and nothing is moving every week someone is coming back with this DEA story.
Comment by mdjbrown on Feb 02, 2024 11:22am
s1, so goes the slow moving wheels of progress whether that be the political or scientific machine. Instant gratification is not in eithers vocabulary! That said, once the DEA finally signs off on this decades old argument, it should open doors to those already committed to providing the best CBD available.  Not going to happen over night, but those wheels to success are slowly turning in ...more  
Comment by subaru1 on Feb 02, 2024 11:31am
Mdjbrown i agree with you the wheels are turning very slowly, the recheduling will happen one day but for now it is just speculation and hope and before that all political process be done it might take more then a year after the decision is made and it could be worse with Trump has president.
Comment by mdjbrown on Feb 02, 2024 11:46am
s1, good thing is Medipharm is not solely reliant on the US market, as they are also targetting and embedded in countries like Germany, Brazil, Austrailia, etc, where politics moves at differing paces and agendas.    Got to be in it to win it, and Labs has a pretty large global foot print in those exciting upstarts, so now we wait patiently for those who have the power to make it ...more  
Comment by subaru1 on Feb 02, 2024 11:53am
Qrt4 results will means a lot, revenue wise, cost reduction, Ebitda, there hasn't been any news regarding new product or shipment or any contract since many months now so let's find out what the reality is with Labs presently.
Comment by subaru1i on Feb 02, 2024 12:59pm
Sorry Debbie Downer, you're on ignore. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities